How Michael Burry's Picks are Playing Out In 2025 ?
Introduction
In his Q4 2024 13F filing, Michael Burry’s Scion Asset Management disclosed 13 positions valued at $77.4 million. From those reported prices to today’s marks (April 30, 2025), outcomes vary widely: Alibaba up +40.21%, Molina Healthcare up +9.88%, while VF Corp. plunged –45.48% and Bruker –32.04%. Below we update each holding’s reported vs. current price performance and explore Burry’s likely rationale given early 2025 market themes.
Q4 2024 Portfolio at a Glance
| Company (Ticker) | Reported Price | Current Price | % Difference |
|---|---|---|---|
| Alibaba (BABA) | $84.79 | $118.88 | +40.21% |
| American Coastal (ACIC) | $13.46 | $11.59 | –13.89% |
| Baidu (BIDU) | $84.31 | $89.46 | +6.11% |
| Bruker (BRKR) | $58.62 | $39.84 | –32.04% |
| Canada Goose (GOOS) | $10.03 | $8.16 | –18.64% |
| Estée Lauder (EL) | $74.98 | $59.59 | –20.53% |
| HCA Healthcare (HCA) | $300.15 | $340.58 | +13.47% |
| JD.com (JD) | $34.67 | $32.88 | –5.16% |
| Magnera (MAGN) | $18.17 | $14.75 | –18.82% |
| Molina Healthcare (MOH) | $291.05 | $319.82 | +9.88% |
| Oscar Health (OSCR) | $13.44 | $13.15 | –2.16% |
| Pinduoduo (PDD) | $96.99 | $104.15 | +7.38% |
| VF Corp. (VFC) | $21.46 | $11.70 | –45.48% |
China Tech Reassessment
Alibaba, JD.com, Baidu & Pinduoduo
Burry’s China tech bets remain central: Alibaba up +40.21%, Baidu +6.11%, Pinduoduo +7.38%, while JD.com trails at –5.16% amid margin pressure.
Healthcare & Insurance
Molina Healthcare, HCA Healthcare, Oscar Health & American Coastal
Defensive plays: Molina Healthcare +9.88%; HCA Healthcare +13.47%; Oscar Health –2.16%; American Coastal –13.89%.
Consumer Brands
Estée Lauder, VF Corp. & Canada Goose
Contrarian bets: Estée Lauder –20.53%, VF Corp. –45.48%, Canada Goose –18.64%.
Industry & Science
Bruker & Magnera
Bruker –32.04%; Magnera –18.82%. Both reflect industrial risks and special situations.
The Big Picture
- Value vs Growth: Healthcare and China tech gains offset steep consumer/industrial losses.
- Rate Environment: Preference for cash-rich, defensive sectors amid rising rates.
- Thematic Balance: Blended U.S./China exposure for geographic diversification.
- Deep Value Tilt: Significant drawdowns reflect Burry’s high-conviction contrarian stance.
Conclusion
As of April 30, 2025, Burry’s Q4 2024 portfolio showcases both outsized winners—Alibaba (+40.21%), HCA (+13.47%)—and deep drawdowns—VF Corp (–45.48%), Bruker (–32.04%). His diversified yet contrarian mix underlines a multifaceted value approach in early 2025.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Please conduct your own research or consult a licensed advisor before making any investment decisions.
